These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2944924)

  • 1. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
    Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
    J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
    Georgotas A; McCue RE; Cooper TB
    Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline.
    Rush AJ; Weissenburger J; Vasavada N; Orsulak PJ; Fairchild CJ
    J Clin Psychopharmacol; 1988 Dec; 8(6):421-5. PubMed ID: 3069882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline.
    Kin NM; Nair NP; Amin M; Schwartz G; Ahmed SK; Holm P; Katona C; Kragh-Sorensen P; Klitgaard N; Song WY; West TE; Stage K
    Biol Psychiatry; 1997 Nov; 42(10):925-31. PubMed ID: 9359979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State specificity of DST abnormalities in geriatric depression.
    Meyers BS; Alpert S; Gabriele M; Kakuma T; Kalayam B; Alexopoulos GS
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):108-14. PubMed ID: 8373930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test in depressive illness: clinical correlates.
    Asnis GM; Halbreich U; Nathan RS; Ostrow L; Novacenko H; Endicott J; Sachar EJ
    Psychoneuroendocrinology; 1982; 7(4):295-301. PubMed ID: 6820157
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of response to antidepressants in elderly patients.
    Georgotas A; McCue RE; Cooper T; Chang I; Mir P; Welkowitz J
    Biol Psychiatry; 1987 Jun; 22(6):733-40. PubMed ID: 3297176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants.
    Saran AS
    J Clin Psychiatry; 1985 Aug; 46(8):335-8. PubMed ID: 4019422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype.
    Robbins DR; Alessi NE; Colfer MV
    J Affect Disord; 1989; 17(2):99-104. PubMed ID: 2527896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
    Georgotas A; Stokes PE; Krakowski M; Fanelli C; Cooper T
    Biol Psychiatry; 1984 May; 19(5):685-93. PubMed ID: 6733180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the dexamethasone suppression test. A placebo-controlled study.
    Peselow ED; Stanley M; Filippi AM; Barouche F; Goodnick P; Fieve RR
    Br J Psychiatry; 1989 Nov; 155():667-72. PubMed ID: 2532946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test and selection of antidepressant medications.
    Greden JF; Kronfol Z; Gardner R; Feinberg M; Mukhopadhyay S; Albala AA; Carroll BJ
    J Affect Disord; 1981 Dec; 3(4):389-96. PubMed ID: 6459354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.